Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126050431 | 12605043 | 1 | I | 20160726 | 20160728 | 20160728 | EXP | PHHY2016VE103798 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160729 | MD | VE | VE |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126050431 | 12605043 | 1 | PS | TRILEPTAL | OXCARBAZEPINE | 1 | Oral | UNK UNK, QD | 21285 | SUSPENSION | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126050431 | 12605043 | 1 | Seizure |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126050431 | 12605043 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126050431 | 12605043 | Autism | |
126050431 | 12605043 | Mutism | |
126050431 | 12605043 | Nasopharyngitis | |
126050431 | 12605043 | Seizure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126050431 | 12605043 | 1 | 201511 | 0 |